Literature DB >> 10567736

Neurotrophin receptors (Trk A, Trk B, and Trk C) in the developing and adult human retina.

T C Nag1, S Wadhwa.   

Abstract

In this study, the ontogeny and distribution patterns of three neurotrophin receptors (Trk A, Trk B, and Trk C) were examined in the human retinas. Immunohistochemistry was performed on sections of retina and optic nerve from fetuses (11-24 weeks of gestation, wg), one infant (4-month-old) and two adult (35- and 65-years-old) subjects. At 11 wg, Trk A was expressed in the nerve fiber and inner plexiform layers, while Trk B and Trk C were expressed in many neuroblastic cells. By 16-17 wg, the photoreceptors showed immunoreactivity for all three receptors. The ganglion cell layer and amacrine cells were conspicuously immunoreactive for Trk A and Trk C, but labeled diffusely for Trk B. The horizontal cells were labeled for Trk A and Trk B. The pattern was same in the retinas at midgestation (20-21 wg). Shortly after this period, there was an apparent decrease in receptor immunoreactivity in the fetal retinas. In the infant retina, Trk A immunoreactivity was absent from horizontal cells. The photoreceptors were immunopositive for Trk B and Trk C, in infant and adult retinas. In the adults, few cells of the ganglion cell layer and inner nuclear layer were clearly labeled for Trk A and Trk C, and diffusely for Trk B. The glial cells of the retina and optic nerve immunoreacted for Trk A only, right from fetal 16 wg. The early expression of Trk B and Trk C on neuroblastic cells suggests that both play a role in cell proliferation. The developmental distribution pattern of Trk A, on the other hand, provides evidence for its involvement in differentiation of the inner plexiform layer, horizontal cells and neuroglia. The results strongly suggest that photoreceptor development is mediated by Trk receptors. The novel localization of Trk B and Trk C on adult photoreceptors points to a possible therapeutic potential for BDNF and NT-3, respectively, in photoreceptor diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567736     DOI: 10.1016/s0165-3806(99)00121-2

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  6 in total

1.  Müller cells derived neurotrophin-3 inhibits hypoxia-induced photoreceptor apoptosis via the TrkC/ERK pathway.

Authors:  Na Li; Yanji Zhu; Jing Wang; Minqi Zhu; Shuang Gao; Qi Chen; Xi Shen
Journal:  Cytotechnology       Date:  2019-11-25       Impact factor: 2.058

2.  Overexpression of neurotrophin-3 stimulates a second wave of dopaminergic amacrine cell genesis after birth in the mouse retina.

Authors:  Miho Yoshida; Liang Feng; François Grimbert; Krsna V Rangarajan; William Buggele; David R Copenhagen; Jianhua Cang; Xiaorong Liu
Journal:  J Neurosci       Date:  2011-08-31       Impact factor: 6.167

Review 3.  Muller glia in retinal innate immunity: a perspective on their roles in endophthalmitis.

Authors:  Ashok Kumar; Rajeev K Pandey; Lindsay J Miller; Pawan K Singh; Mamta Kanwar
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

4.  A novel p75 neurotrophin receptor-related protein, NRH2, regulates nerve growth factor binding to the TrkA receptor.

Authors:  Simon S Murray; Pilar Perez; Ramee Lee; Barbara L Hempstead; Moses V Chao
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

5.  Brain-derived neurotrophic factor in infants <32 weeks gestational age: correlation with antenatal factors and postnatal outcomes.

Authors:  Rakesh Rao; Charles B Mashburn; Jingnan Mao; Nitin Wadhwa; George M Smith; Nirmala S Desai
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

6.  NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study.

Authors:  Benedetto Falsini; Giancarlo Iarossi; Antonio Chiaretti; Antonio Ruggiero; Luigi Manni; Manni Luigi; Lucia Galli-Resta; Giovanni Corbo; Edoardo Abed
Journal:  J Transl Med       Date:  2016-01-09       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.